Competition heats up in domestic allergic rhinitis market

Published: 2012-09-27 06:59:00

Updated: 2012-09-27 06:59:00

Competition in the local allergic rhinitis market is heating up because generic manufacturers are increasing efforts to occupy the runner-up slot by deploying aggressive marketing strategies.

The domestic allergic rhinitis market is valued at 200 billion won, which is predominated by Merck’s S...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK